Deintensification Strategies Using Proton Beam Therapy for HPV-Related Oropharyngeal Cancer

• Main Authors: Mauricio E. Gamez, MD, Daniel J. Ma, MD
• Format: Article
• Language: English
• Published: Particle Therapy Co-operative Group 2021-06-01
• Series: International Journal of Particle Therapy
• Subjects: hpv; oropharyngeal cancer; deintensification; protons
• Online Access: https://theijpt.org/doi/pdf/10.14338/IJPT-20-00073.1

Oropharyngeal cancers related to the human papillomavirus are a growing segment of head and neck cancers throughout the world. These cancers are biologically and demographically unique with patients presenting at younger ages and with more curable disease. This combination of factors heightens the importance of normal tissue sparing because patients will live a long time with treatment sequelae. Proton therapy has demonstrated benefits in reducing normal tissue exposure, which may lead to less toxicity, a higher quality of life, less immunologic suppression, and lower cost. Research investigating deintensified radiation volumes and doses are also underway. These deintensification studies synergize well with the beam characteristics of proton beam therapy and can decrease that already reduced normal tissue exposure enabled by proton therapy. Future studies should refine patient selection to best allow for volume and dose reduction paired with proton therapy.